Key facts
- This page summarizes Fred P. Lampropoulos's Form 4 filing for MERIT MEDICAL SYSTEMS INC (MMSI).
- 1 reported transaction and 3 derivative rows are listed below.
- Accepted by SEC: 26 Nov 2025, 15:22.
Fred P. Lampropoulos - 25 Nov 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)
- Reporting relationship
- Executive Chairman, Director
- Issuer ticker
- MMSI
- Reported as of
- 25 Nov 2025
- Net transaction value
- -$880,377
- SEC form
- 4
- Accepted by SEC
- 26 Nov 2025, 15:22:04 UTC
- Prior SEC filing
- 24 Nov 2025
- Next SEC filing
- 02 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian G. Lloyd, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Fred P. Lampropoulos filed Form 4 for MERIT MEDICAL SYSTEMS INC (MMSI) on 26 Nov 2025.
Change
- Previous filing in this sequence was filed on 24 Nov 2025.
- Current net transaction value: -$880,377.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0000901534
Primary reporting owner
Lampropoulos Fred P.
- Relationship
- Executive Chairman, Director
- Address
- 1600 WEST MERIT PARKWAY, SOUTH JORDAN
- Signature
- /s/ Brian G. Lloyd, Attorney-in-Fact
- Signature date
- 26 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MMSI
transaction
Common Stock, No Par Value
Sale
- Transaction value
- $880,377
- Shares
- -10,000
- Change %
- -0.97%
- Price
- $88.04
- Shares after
- 1,019,955
- Date
- 25 Nov 2025
- Ownership
- Direct
- Footnotes
- F3
MMSI
holding
Common Stock, No Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,280
- Date
- 25 Nov 2025
- Ownership
- By spouse
- Footnotes
- F1
MMSI
holding
Common Stock, No Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 98,132
- Date
- 25 Nov 2025
- Ownership
- By 401(k) Plan
- Footnotes
- F2
MMSI
holding
Common Stock, No Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 90
- Date
- 25 Nov 2025
- Ownership
- By spouse as custodian for child
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MMSI
holding
Derivative
Non-qualified stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100,334
- Date
- 25 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,334
- Exercise price
- $37.71
- Footnotes
- F4
MMSI
holding
Derivative
Non-qualified stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 58,083
- Date
- 25 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,083
- Exercise price
- $56.25
- Footnotes
- F5
MMSI
holding
Derivative
Non-qualified stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 54,302
- Date
- 25 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 54,302
- Exercise price
- $70.58
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
Footnote F2
The 401(k) number represents plan holdings as of 10/31/2025.
Footnote F3
The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.175, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Footnote F4
Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
Footnote F5
Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
Footnote F6
Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.